Mammatech Announces Reverse Split, Company Developing Tactile Computer to Improve Clinical Breast Examination (CBE)

Share Article

The Mammatech Corporation announced today a 20 to 1 reverse split in the company's shares of common stock effective 22 November 2002.

The Mammatech Corporation (MAMH.OB) announced today a 20 to 1 reverse split in the company's shares of common stock effective 22 November 2002. The Company’s 8k stated that it intends to seek financing for new product development. H.S. Pennypacker, Ph.D., President of Mammatech, said, "The company is developing a computer assisted tactile trainer that will help produce and verify high levels of clinical breast examination (CBE) skill.”

Dr. Mark K. Goldstein, Mammatech's Chairman, reported that published studies continue to find that most breast cancers are first detected by someone's hands. The Company’s MammaCare® program is a recognized standard for proficient CBE.

  • The MammaCare® program was developed under grants from the National Cancer Institute.
  • Barton, M. B., Harris, R., & Fletcher, S. W. (1999). Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? Journal of the American Medical Association, 282(13), 1270-1280.

Contact person:                                

Mark Goldstein, Ph.D.

(352) 375 0607

Company website http://www.mammacare.com
Email address science@mammacare.com

The company’s transfer agent is

Manhattan Transfer Registrar Company

57 Eastwood Road,

Miller Place, NY 11764

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mark Goldstein, Ph.D.
Visit website